0       0

HFSA's 19th Annual Scientific Meeting


Late Breaking Clinical Trials


Sep 27, 2015 3:30pm ‐ Sep 27, 2015 5:00pm

Description

Describe the results of recent clinical trials in heart failure and discuss their clinical implications.

Speaker Objective(s):

  • Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure
  • Commentary
  • HeartMate 3 CE Mark Clinical Study
  • Commentary (HeartMate 3)
  • Commentary (NECTAR-HF)
  • Aquarpheresis Versus Diuretics and Hospitalization for Heart Failure Trial (AVOID HF)
  • CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure
  • Commentary (CUPID 2)
  • ENCORE Study
  • Commentary (ENCORE)
  • Neural Cardiac Therapy for Heart Failure (NECTAR-HF)
  • Commentary (AVOID-HF)

Speaker(s):

  • Douglas Mann, MD, PhD, Washington University at St. Louis School of Medicine

Moderator(s):

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content